Alexander Nowak
Stock Analyst at Craig-Hallum
(2.63)
# 2,207
Out of 4,981 analysts
45
Total ratings
44.44%
Success rate
6.11%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $7.87 | +179.54% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $168.51 | -6.83% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $7.23 | +135.29% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $28.57 | +99.51% | 6 | Sep 5, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $54.91 | -50.83% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $13.53 | +10.86% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $7.09 | +12.83% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.70 | +958.82% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $12.27 | +307.50% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $7.11 | +2,150.35% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $53.94 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.89 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.85 | +285.96% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $51.26 | +114.59% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $0.46 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $3.47 | +8,545.53% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $9.99 | +180.28% | 1 | Aug 31, 2020 |
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $7.87
Upside: +179.54%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $168.51
Upside: -6.83%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $7.23
Upside: +135.29%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $28.57
Upside: +99.51%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $54.91
Upside: -50.83%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $13.53
Upside: +10.86%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $7.09
Upside: +12.83%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.70
Upside: +958.82%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $12.27
Upside: +307.50%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $7.11
Upside: +2,150.35%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $53.94
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.89
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.85
Upside: +285.96%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $51.26
Upside: +114.59%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.46
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $3.47
Upside: +8,545.53%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $9.99
Upside: +180.28%